Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine in Children With Recurrent or Refractory Malignancies
NCT00003234Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- May 1998
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label trial of vinorelbine in soft tissue sarcoma (STS), central nervous system tumor and neuroblastoma (3 arms), sponsored by Children's Oncology Group. Primary endpoints: Response Rate and Disease Progression. Started May 1998; status: completed.
02
Drugs
vinorelbine
03
Conditions
soft tissue sarcoma (STS)central nervous system tumorneuroblastoma
Beyond the preview
Go deeper on NCT00003234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003234.